Zelira wins Gov tax refund for cannabinoid research
Biopharma company Zelira Therapeutics has been awarded a $1.2 million cash refund under the Government’s R&D Tax Incentive Scheme, for use on its cannabis-based medical research into autism.
BioCina to scale up novel bioseparation technology
Pharmaceutical and vaccine company BioCina is planning to scale up from laboratory to industrial scale a bioseparation resin technology for the large-scale production of complex medicines made from biopharmaceuticals. Backed by an Australian Economy Accelerator (AEA) grant, Griffith University Institute for Biomedicine and Glycomics Principal Research Leader, Professor Bernd Rehm and his team are leading…
Manufacturing news briefs — stories you might have missed
Rio Tinto spends up big with local suppliers Rio Tinto increased its spend with suppliers and local businesses in Australia to more than $16.1 billion in 2023, as part of the company’s commitment to support communities where it operates. This was an increase of five per cent on the previous year and was spent with…